Colorectal cancer detection in an asymptomatic population: fecal immunochemical test for hemoglobin vs. fecal M2-type pyruvate kinase

INTRODUCTION: Screening programs for colorectal cancer (CRC) are mainly based on a first-line fecal immunochemical test for hemoglobin (FIT). Fecal M2-type pyruvate kinase (M2-PK) has been evaluated in clinical settings showing promising results for early CRC detection. However, the impact of fecal...

Descripción completa

Detalles Bibliográficos
Autores principales: Caviglia, Gian Paolo, Cabianca, Luca, Fagoonee, Sharmila, Gili, Fabrizio M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Croatian Society of Medical Biochemistry and Laboratory Medicine 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4783085/
https://www.ncbi.nlm.nih.gov/pubmed/26981025
http://dx.doi.org/10.11613/BM.2016.012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4783085/
https://www.ncbi.nlm.nih.gov/pubmed/26981025
http://dx.doi.org/10.11613/BM.2016.012

Ejemplares similares